| 2014 ESC/EACTS Guidelines on myocardial revascularization S Windecker, P Kolh, F Alfonso, JP Collet, J Cremer, V Falk, G Filippatos, ... Kardiologia Polska (Polish Heart Journal) 72 (12), 1253-1379, 2014 | 5308 | 2014 |
| Transcatheter aortic valve implantation in failed bioprosthetic surgical valves D Dvir, JG Webb, S Bleiziffer, M Pasic, R Waksman, S Kodali, M Barbanti, ... Jama 312 (2), 162-170, 2014 | 882 | 2014 |
| Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry D Dvir, J Webb, S Brecker, S Bleiziffer, D Hildick-Smith, A Colombo, ... Circulation 126 (19), 2335-2344, 2012 | 659 | 2012 |
| Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein (a) short-term and long-term immunologic responses to oxidized low … S Tsimikas, HK Lau, KR Han, B Shortal, ER Miller, A Segev, LK Curtiss, ... Circulation 109 (25), 3164-3170, 2004 | 292 | 2004 |
| Deformation dynamics and mechanical properties of the aortic annulus by 4-dimensional computed tomography: insights into the functional anatomy of the aortic valve complex and … A Hamdan, V Guetta, E Konen, O Goitein, A Segev, E Raanani, ... Journal of the American College of Cardiology 59 (2), 119-127, 2012 | 238 | 2012 |
| Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation A Hamdan, V Guetta, R Klempfner, E Konen, E Raanani, M Glikson, ... JACC: Cardiovascular Interventions 8 (9), 1218-1228, 2015 | 211 | 2015 |
| Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor … D Aviezer, S Cotton, M David, A Segev, N Khaselev, N Galili, Z Gross, ... Cancer Research 60 (11), 2973-2980, 2000 | 200 | 2000 |
| Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017 H Dai, Q Zhang, AA Much, E Maor, A Segev, R Beinart, S Adawi, Y Lu, ... European Heart Journal-Quality of Care and Clinical Outcomes 7 (6), 574-582, 2021 | 184 | 2021 |
| Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation IM Barbash, M Barbanti, J Webb, J Molina-Martin De Nicolas, ... European heart journal 36 (47), 3370-3379, 2015 | 154 | 2015 |
| Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System V Guetta, G Goldenberg, A Segev, D Dvir, R Kornowski, A Finckelstein, ... The American journal of cardiology 108 (11), 1600-1605, 2011 | 150 | 2011 |
| Predictors and 1-year outcome of major bleeding in patients with non–ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries A Segev, BH Strauss, M Tan, C Constance, A Langer, SG Goodman, ... American heart journal 150 (4), 690-694, 2005 | 128 | 2005 |
| The role of perlecan in arterial injury and angiogenesis A Segev, N Nili, BH Strauss Cardiovascular Research 63 (4), 603-610, 2004 | 128 | 2004 |
| Clinical characterization of 162 COVID-19 patients in Israel: preliminary report from a large tertiary center. E Itelman, Y Wasserstrum, A Segev, C Avaky, L Negru, D Cohen, ... Isr Med Assoc J, 271-274, 2020 | 122 | 2020 |
| BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response Y Peled, E Ram, J Lavee, L Sternik, A Segev, A Wieder-Finesod, ... The Journal of Heart and Lung Transplantation 40 (8), 759-762, 2021 | 115 | 2021 |
| The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement G Witberg, E Regev, S Chen, A Assali, IM Barbash, D Planer, ... JACC: Cardiovascular Interventions 10 (14), 1428-1435, 2017 | 99 | 2017 |
| Third dose of the BNT162b2 vaccine in heart transplant recipients: immunogenicity and clinical experience Y Peled, E Ram, J Lavee, A Segev, S Matezki, A Wieder-Finesod, ... The Journal of Heart and Lung Transplantation 41 (2), 148-157, 2022 | 91 | 2022 |
| Collagenase plaque digestion for facilitating guide wire crossing in chronic total occlusions BH Strauss, L Goldman, B Qiang, N Nili, A Segev, J Butany, JD Sparkes, ... Circulation 108 (10), 1259-1262, 2003 | 87 | 2003 |
| Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting A Segev, S Kassam, CE Buller, HK Lau, JD Sparkes, PW Connelly, ... European heart journal 25 (12), 1029-1035, 2004 | 86 | 2004 |
| High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors A Segev, MH Ellis, F Segev, Z Friedman, T Reshef, JD Sparkes, J Tetro, ... International journal of cardiology 98 (3), 421-424, 2005 | 82 | 2005 |
| Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning based clinical decision support system in an inpatient setting G Segal, A Segev, A Brom, Y Lifshitz, Y Wasserstrum, E Zimlichman Journal of the American Medical Informatics Association 26 (12), 1560-1565, 2019 | 77 | 2019 |
